Archive | August, 2017

M&A Theme Continues To Boost Biotech Stocks

M&A Boosts Biotech Stocks For Third Day Gilead Sciences (GILD) and bluebird bio (BLUE) Both Soar Today  Biotech Sector Back to 2017 Highs The prospect of more M&A boosts biotech stocks for a third day this week. The large cap based IBB was up 1.87% today and  6.48% over five days to $323.76 approaching its […]

Continue Reading 0

At Last A Deal Sparks Biotech Rally: Gilead Buys Kite for $11.9B+…Update-1

Update–11:30am Aug 28 Green Screen in Biotech Especially CAR-T Plays (BLUE,CLLS,JUNO) NASDAQ up a tad 0.21%, but broad market flattish. Biotech Deal Boosts ETFs: FBT up 2.71%, IBB up 1.53%, XBI up 2.53%. Bellwether Celgene (CELG) up 1.4%. AMGN up 1.24%, BIIB up 2.67%, GILD up 1.57%. Mid-Caps: ICPT up 1.98%, INCY up 0.9%, JUNO […]

Continue Reading 0

Vacation ’till August 26 Unless Unusual Vol

Not Much To Report-Vacation Doldrums Momentum Has Eased a Tad Investors Expecting Growth from Large Caps and M&A from Mid-Caps. We are on vacation until August 25 unless big news and volatility breaks. Here is where we are as of August 15: IBB at $309.31 off July peak YTD of $327, up 16.55% YTD. XBI […]

Continue Reading 0

Biotech Snapshot on a Rally Day…Update-2

8/10 Red Screen in the Morning We cautioned on XBI at $78 on 7/31 and today it broke through support at $75 to $74.70. ======= 8/9 Update After Close: A Bit of Caution after Trump’s “Fire and Fury” Talk Investors are holding off as global risks rise but biotech and healthcare holds July bottom (XBI $75-76) […]

Continue Reading 0

Large Cap Biopharma Earnings Boost Stocks: Update 8/1/17

Rayno Large Cap Biopharma Earnings Summary 8/1/17 Biotech Stocks Hit Highs in Mid-July up 18%, 30% on XBI (Click on “urls” below for Company Press Release) All the large cap biopharmaceutical earnings have come in except Regeneron (REGN) which will report on August 3.  Stocks were broadly higher in July after financial reports, however we suggested […]

Continue Reading 0